<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>21627342</Do_id>
  <Journal>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</Journal>
  <Doc_title>Imatinib: as adjuvant therapy for gastrointestinal stromal tumorâ€ : profile report.</Doc_title>
  <Doc_abstract>None</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Protein Kinase Inhibitors;Pyrimidines;Imatinib Mesylate</Doc_ChemicalList>
  <Doc_meshdescriptors>Antineoplastic Agents;Benzamides;Clinical Trials as Topic;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Piperazines;Protein Kinase Inhibitors;Pyrimidines</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapeutic use;drug therapy;therapeutic use;therapeutic use;therapeutic use</Doc_meshqualifiers>
</Document>
